✦ LIBER ✦

Treatment of gram-negative folliculitis with isotretinoin

✍ Scribed by U. Neubert; G. Plewig; A. Ruhfus

Publisher: Springer-Verlag
Year: 1986
Tongue: English
Weight: 548 KB
Volume: 278
Category: Article
ISSN: 0340-3696
DOI: 10.1007/bf00407743

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Organisms associated with Gram-negative

Organisms associated with Gram-negative folliculitis: In vitro growth in the presence of isotretinoin

✍ S. Simjee; D. F. Sahm; K. Soltani; J. A. Morello 📂 Article 📅 1986 🏛 Springer-Verlag 🌐 English ⚖ 248 KB

Treatment of gram-negative bacillary sep

Treatment of gram-negative bacillary septicemia with cefoperazone

✍ Lagast, H. ;Meunier-Carpentier, F. ;Klastersky, J. 📂 Article 📅 1983 🏛 Springer-Verlag ⚖ 399 KB

The treatment of gram-negative bacillary

The treatment of gram-negative bacillary septicemia with cefoperazone

✍ H. Lagast; J. Klastersky 📂 Article 📅 1981 🏛 Springer-Verlag 🌐 English ⚖ 581 KB

Treatment of acne with intermittent isot

Treatment of acne with intermittent isotretinoin

✍ V. GOULDEN; S.M. CLARK; C. MCGEOWN; W.J. CUNLIFFE 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 264 KB

Adults with acne represent an increasingly important population of acne sufferers referred for treatment. Acne, in these patients, is generally mild or moderate in severity but tends to be resistant to conventional antibiotic therapy. A study was carried out to assess the efficacy of intermittent mo

Endotoxin Antagonists: Possible Candidat

Endotoxin Antagonists: Possible Candidates for the Treatment of Gram-Negative Sepsis

✍ Priv.-Doz. Dr. Otto Holst 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 375 KB

Prophylactic treatment of gram-positive

Prophylactic treatment of gram-positive and gram-negative abdominal implant infections using locally delivered polyclonal antibodies

✍ Poelstra, Kornelis A. ;Barekzi, Nazir A. ;Rediske, Andrea M. ;Felts, Adrian G. ; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 285 KB

## Abstract The increasing clinical incidence and host risk of biomaterial‐centered infections, as well as the reduced effectiveness of clinically relevant antibiotics to treat such infections, provide compelling reasons to develop new approaches for treating implanted biomaterials in a surgical co